Mindpro-Plus Tablet SR is a controlled-release formulation containing a fixed combination of 40mg propranolol and 10mg flunarizine. This oral medication is indicated for the treatment of anxiety disorders, including generalized anxiety disorder and anxiety associated with depression. Propranolol, a beta-blocker, helps to reduce symptoms of anxiety and panic by blocking the actions of stress hormones, such as adrenaline. Flunarizine, a calcium channel blocker, contributes to the medication's anxiolytic and anti-inflammatory effects, while also exhibiting anticonvulsant and sedative properties. The sustained-release formulation of Mindpro-Plus Tablet SR allows for a gradual release of the active ingredients over a prolonged period, providing a prolonged duration of therapeutic effect. The medication is available in a tablet form with a SR coating, which ensures a controlled release of the active ingredients over a period of 12 hours. Mindpro-Plus Tablet SR is contraindicated in patients with known hypersensitivity to the active ingredients, and caution should be exercised in patients with a history of depression, heart failure, or chronic obstructive pulmonary disease.